The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma-Reference-Cited by-同舟云学术

The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma

Published:2024-05-23 Issue:9 Volume:79 Page:2346-2365
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Agache Ioana¹^ORCID,Ricci‐Cabello Ignacio²³⁴⁵,Canelo‐Aybar Carlos⁵⁶,Annesi‐Maesano Isabella⁷^ORCID,Cecchi Lorenzo⁸^ORCID,Biagioni Benedetta⁹,Chung Kian Fan¹⁰^ORCID,D'Amato Gennaro¹¹¹²^ORCID,Damialis Athanasios¹³^ORCID,del Giacco Stefano¹⁴^ORCID,De Las Vecillas Leticia¹⁵^ORCID,Dominguez‐Ortega Javier¹⁵,Galán Carmen¹⁶^ORCID,Gilles Stefanie¹⁷^ORCID,Giovannini Mattia¹⁸¹⁹,Holgate Stephen²⁰,Jeebhay Mohamed²¹^ORCID,Nadeau Kari²²^ORCID,Papadopoulos Nikolaos²³²⁴^ORCID,Quirce Santiago¹⁵,Sastre Joaquin²⁵,Traidl‐Hoffmann Claudia¹⁷²⁶²⁷^ORCID,Walusiak‐Skorupa Jolanta²⁸,Salazar Josefina⁵,Sousa‐Pinto Bernardo²⁹,Colom Miquel²⁵,Fiol‐deRoque Maria A.²³⁵³⁰,Gorreto López Lucía⁵³¹,Malih Narges²³⁵,Moro Laura⁵^ORCID,Pardo Marina García⁵³²,Pazo Patricia García²⁵,Campos Rocío Zamanillo²³⁵,Saletti‐Cuesta L.⁵,Akdis Mubeccel³³^ORCID,Alonso‐Coello Pablo⁴⁵⁶,Jutel Marek³⁴^ORCID,Akdis Cezmi A.³³^ORCID

Affiliation:

1. Faculty of Medicine Transylvania University Brasov Romania

2. Research Group in Primary Care and Promotion – Balearic Islands Community (GRAPP‐caIB) Health Research Institute of the Balearic Islands (IdISBa) Palma Spain

3. Primary Care Research Unit of Mallorca Balearic Islands Health Services Palma Spain

4. CIBER Biomedical Research Center in Epidemiology and Public Health (CIBERESP) Health Institute Carlos III (ISCIII) Madrid Spain

5. Iberoamerican Cochrane Centre Barcelona Spain

6. Institut de Recerca Sant Pau (IR SANT PAU) Barcelona Spain

7. Institute Desbrest of Epidemiology and Public Health, INSERM, University Hospital, University of Montpellier Montpellier France

8. SOSD Allergy and Clinical Immunology USL Toscana Centro Prato Italy

9. Allergy and Clinical Immunology Unit San Giovanni di Dio Hospital Florence Italy

10. Imperial College London UK

11. Respiratory Disease Department Hospital Cardarelli Naples Italy

12. Medical School of Respiratory Allergy University of Naples Federico II Naples Italy

13. Terrestrial Ecology and Climate Change, Department of Ecology, School of Biology, Faculty of Sciences Aristotle University of Thessaloniki Thessaloniki Greece

14. Department of Medical Sciences and Public Health University of Cagliari Monserrato Italy

15. Department of Allergy Hospital La Paz Institute for Health Research (IdiPAZ) Madrid Spain

16. Inter‐University Institute for Earth System Research (IISTA), International Campus of Excellence on Agrifood (ceiA3), University of Córdoba Córdoba Spain

17. Environmental Medicine, Faculty of Medicine University of Augsburg Augsburg Germany

18. Allergy Unit Meyer Children's Hospital IRCCS Florence Italy

19. Department of Health Sciences University of Florence Florence Italy

20. Faculty of Medicine University of Southampton Southampton UK

21. Occupational Medicine Division and Centre for Environmental & Occupational Health Research University of Cape Town Cape Town South Africa

22. John Rock Professor of Climate and Population Studies Chair, Department of Environmental Health, Interim Director, Center for Climate, Health, and the Global Environment, Harvard T.H. Chan School of Public Health Boston Massachusetts USA

23. Allergy and Clinical Immunology Unit, Second Pediatric Clinic National and Kapodistrian University of Athens Athens Greece

24. Division of Evolution and Genomic Sciences University of Manchester Manchester UK

25. Allergy Service, Fundación Jiménez Díaz Faculty of Medicine Universidad Autónoma de Madrid and CIBERES, Instituto Carlos III, Ministry of Science and Innovation Madrid Spain

26. Institute of Environmental Medicine, Helmholtz Munich – German Research Center for Environmental Health Augsburg Germany

27. Christine‐Kühne Center for Allergy Research and Education Davos Switzerland

28. Department of Occupational Diseases and Environmental Health Nofer Institute of Occupational Medicine Lodz Poland

29. MEDCIDS – Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine University of Porto Porto Portugal

30. Prevention and Health Promotion Research Network (redIAPP)/Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) Barcelona Spain

31. Gabinete técnico de atención primaria de Mallorca, Balearic Islands Health Services Palma Spain

32. Servicio de urgencias de atención primaria de Inca, Balearic Islands Health Services Palma Spain

33. Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich Davos Switzerland

34. Department of Clinical Immunology Wrocław Medical University, ALL‐MED Medical Research Institute Wroclaw Poland

Abstract

AbstractTo inform the clinical practice guidelines' recommendations developed by the European Academy of Allergy and Clinical Immunology systematic reviews (SR) assessed using GRADE on the impact of environmental tobacco smoke (ETS) and active smoking on the risk of new‐onset asthma/recurrent wheezing (RW)/low lung function (LF), and on asthma‐related outcomes. Only longitudinal studies were included, almost all on combustion cigarettes, only one assessing e‐cigarettes and LF. According to the first SR (67 studies), prenatal ETS increases the risk of RW (moderate certainty evidence) and may increase the risk of new‐onset asthma and of low LF (low certainty evidence). Postnatal ETS increases the risk of new‐onset asthma and of RW (moderate certainty evidence) and may impact LF (low certainty evidence). Combined in utero and postnatal ETS may increase the risk of new‐onset asthma (low certainty evidence) and increases the risk of RW (moderate certainty evidence). According to the second SR (24 studies), ETS increases the risk of severe asthma exacerbations and impairs asthma control and LF (moderate certainty evidence). According to the third SR (25 studies), active smoking increases the risk of severe asthma exacerbations and of suboptimal asthma control (moderate certainty evidence) and may impact asthma‐related quality‐of‐life and LF (low certainty evidence).

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.16151

Reference169 articles.

1. Trends in worldwide asthma prevalence

2. Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

3. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

4. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

5. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indoor and outdoor pollutants—No safe amount of air to breathe in;Allergy;2024-06-23